COV ASX · Health Care

Cleo Diagnostics Ltd

Announcements, last 12 months: 45
Price sensitive, last 12 months: 24
Followed on InvestorPA: Low (Outside the 20% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
21 Oct 2026, 9:03 AM	CLEO Screening Test Meets Rigorous Performance Targets Price sensitive	AI summary
13 Oct 2026, 8:50 AM	CLEO Commences Analytical Validation Ahead of FDA Submission Price sensitive	AI summary
30 Sep 2026, 8:52 AM	Cleo Files Patents for its Ovarian Cancer Screening Test Price sensitive	AI summary
24 Sep 2026, 9:09 AM	CLEO Commences Ovarian Cancer Screening Test Development Price sensitive	AI summary
17 Sep 2026, 10:18 AM	Letter to Shareholders
17 Sep 2026, 10:14 AM	Notice of Annual General Meeting/Proxy Form
10 Sep 2026, 5:01 PM	Notice Required Under ASX Listing Rule 3.13.1
10 Sep 2026, 9:14 AM	CLIA Certified Lab selected - Pivotal US Clinical Validation Price sensitive	AI summary
3 Sep 2026, 8:55 AM	CLEO Receives First Batch of Commercial Test Kits Price sensitive	AI summary
24 Aug 2026, 4:33 PM	Change of Director's Interest Notice x 4

Sign in to see all COV announcements.

Guidance history

29 Jul 2026	FDA submission in H1 CY2027
13 Jul 2026	AV expected to take ~4 months to complete, FDA submission anticipated in H1 CY2027
28 Apr 2026	No high-importance, price-sensitive forward-looking financial metrics provided.

Sign in to see the full guidance history.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow COV to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.